Elixirgen Therapeuticsincis A Clinical Stage Biotechnology Company Based In Baltimoremarylandfounded In 2018 By Drminoru Kothe Company Focuses On Developing Rna Based Therapies For Rare Diseases And Aging Associated Disorderselixirgen Is Advancing Its Lead Candidateexg 34217Which Targets Telomere Biology Disorders And Has Received Fda Orphan Drug Designation The Company Utilizes Proprietary Technologiesincluding C Srrnaa Cwhich Allows For Controlled Therapeutic Protein Expressionand Zscan4 Based Therapies That Aim To Stabilize Genomes And Elongate Telomereselixirgen S Research Is Conducted In State Of The Art Facilities At The Science Technology Park At Johns Hopkinswhere It Collaborates With Academic Institutions To Enhance Its Capabilitiesthe Company Is Actively Recruiting Professionals In Rna Technology And Cell Therapy Development To Support Its Mission
No conferences found for this company.
| Company Name | Elixirgen Therapeutics Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
